Director, Multiple Myeloma and Amyloidosis Program
Cedars-Sinai Medical Center
Robert Vescio, MD
Director Multiple Myeloma and Amyloidosis Program
Samuel Oschin Cancer Center
Cedars-Sinai Medical Center
Los Angeles, CA 90048
Robert A. Vescio, MD, is the Director of the Multiple Myeloma and Amyloidosis Program at the Saumel Oschin Cancer Center at Cedars-Sinai in Los Angeles, California where he is also a Clinical Professor of Medicine. He is board certified in both medical oncology and hematology.
He received his medical degree from the University of California, San Diego (UCSD) Medical School where he also completed his internship and residency. He completed his hematologyoncology fellowship at the University of California, Los Angeles (UCLA) Medical Center.
He has received numerous awards including being cited as one of America’s Top Doctors for Cancer repetitively over the past ten years. He focuses his work exclusively on multiple myeloma, amyloidosis and related conditions. His research has been both clinical and laboratory based. His laboratory work has led to an improved understanding of multiple myeloma etiology and pathogenesis. His clinical work has centered upon the use of conventional, high-dose chemotherapy (autologous transplantation) and more recently the use of novel and immunotherapeutic approaches for these diseases. He has served as a principal investigator in numerous clinical trials often leading to approval of new drug agents for the treatment of multiple myeloma.
Dr Vescio has published numerous book chapters and over 100 articles in peer-reviewed journals, including Blood, Science, Bone Marrow Transplantation, Lancet, Journal of Clinical Oncology and the Proceedings of the National Academy of Science. He is a frequent lecturer providing education and sharing his expertise with other hematologists and oncologists about the latest therapies for multiple myeloma and amyloidosis throughout the United States.